Gamma Knife Market
Increase in the Number of Cancer Patients to Surge the Demand for Gamma Knife. FMI Presents Detailed Analysis to Understand the Potential in 30+ Countries
Gamma Knife Market by Disease Indication, Anatomy & Region – Forecast 2023–2033
Gamma Knife Market Outlook (2023-2033)
The global gamma knife market is expected to grow at a CAGR of 5.7% during the period 2023-2033. The market holds a valuation of US$ 343.1 million as of 2023, and by 2033, the market is expected to reach a valuation of US$ 600 million.
The key factors expected to drive the adoption of gamma knife surgeries include:
- Increase preference toward non- and minimally-invasive procedures
- High success rate of Gamma Knife treatment
- Positive perception among healthcare providers
- Focus on developed novel treatment procedures for neurological disorders
- Comprehensive health insurance cover radiation therapy
There has been an increase in neurological disorders worldwide, which has led to increasing demand for non-invasive procedures. Based on the statistics, there is an increase in neurological disorders, especially among the geriatric population. This is expected to surge the demand for gamma knife during the forecast period.
Apart from that, an increase in the number of cancer cases worldwide is also expected to increase the market share of gamma knife during the forecast period. Based on a survey conducted by cancer.org, by 2040, the world might witness over 27.5 million new cancer cases and 16. Million cancer deaths. Moreover, based on research published by the American Cancer Society, brain cancer is considered the third highest cause of death among people aged 40 plus. Thus, proactive measures taken by people experiencing even the lightest of symptoms are expected to have a positive effect on the gamma knife adoption trends.
Furthermore, growing technological advancements in the healthcare sector are expected to further surge the market share. The gamma knife makes use of computer guided treatment device, which allows the surgeons to perform the operation with higher precision. The ability to deliver strong radiation beams to treat brain tumours and lesions, arteriovenous malformations, acoustic neuroma, tremors, and trigeminal neuralgia is expected to further increase the sales of gamma knife going ahead.
Apart from being a non-invasive procedure, the patients do not experience any pain while undergoing the procedure. This is because of the fact that no damage to the nearby cell is caused in this process which makes it relatively seamless. Furthermore, there are no side effects involved in the process, which makes it one of the most highly sought-after procedures in the current times.
On the back of exhaustive research on its efficacy and high success rate, Gamma Knife continues to gain traction among healthcare centres as a highly effective radiosurgery system. Linear Accelerator (LINAC) remains the widely used radiation therapy treatment procedure – nearly 50% of patients undergoing radiation therapy were treated using LINAC.
Gamma Knife and Cyber Knife are the two widely used stereotactic radiation therapy procedures. The global gamma knife equipment revenues were estimated at US$ 172 million in 2015, and since then, the product has been successful in gaining a decent amount of traction.
|
Attributes |
Value |
|
Gamma Knife Market Value (2022) |
US$ 313.8 million |
|
Gamma Knife Market Value (2023) |
US$ 343.1 million |
|
Gamma Knife Market Forecast Value (2033) |
US$ 600 million |
|
Gamma Knife Market Expected CAGR (2023 to 2033) |
5.7% |
Let us know your requirement to get
100% FREE customization
Historical CAGR (2017-2022) vs Anticipated CAGR: Way Ahead for Gamma Knife Market
On comparing the historical CAGR with the anticipated CAGR, we would get a sense of what might lead to a leaner patch during the forecast period. While the historical CAGR for the market was nearly 9%, the anticipated CAGR is 5.7%. The availability of affordable alternatives might have led to the reduction of CAGR.
However, in certain parts of the world, the drug authorities have started giving them clearances and are personally in favour of their usage. For example, in the USA, Elekta announced that Elekta Esprit, a new Leksell gamma knife radiosurgery platform, received FDA 510(k) clearance. This milestone makes the system available to clinicians and people with brain disease in the U.S., as well as opening the door to other countries where FDA approval is recognized.
Rising Obesity Worldwide to Surge Gamma Knife Market
Surging obesity cases worldwide are expected to be one of the key growth factors for the gamma knife market. The surgeons are motivating obese patients to opt for the gamma knife method for treating obesity, as it is a non-invasive procedure. Based on a survey conducted, non-invasive procedures account for more than 50% of the aesthetic medicine market share, which represents massive scope for the gamma knife market.
Apart from that, governments worldwide are investing huge amounts in promoting non-invasive procedures in order to ensure complete wellness for their citizens. This is owing to the fact that gamma knife surgery makes use of the latest technology, and the technological upgradation would certainly be in sync with healthcare improvement.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystImaging Software Implementation to spur Massive Growth
Growing methodical use of integrated imaging software to keep a constant check on the amount of dose delivery is expected to fuel demand for gamma knife in the assessment period. The market will also gain from the rapid development of radiation devices and innovations to ensure minimal invasions and reduced post-surgical complications in surgery.
Some of the leading companies are focusing on innovations to offer advanced patient care. For instance, Elekta, a key leader in precision radiation medicine, announced the launch of its new Leksell Gamma Knife Lightning, a leading-edge innovation for intracranial stereotactic radiosurgery. This innovation completely aligns with Elekta’s developmental strategy focused on contributing to the healthcare sector by enhancing operational efficiency, minimizing drafting time and equipping physicians to concentrate significantly on patient-centric care.
Increased Collaborations to present Massive Opportunities
Increased focus on acquisitions and collaborations is expected to increase in the coming years and might act as one of the key trends impacting the gamma knife industry. For instance, Brainlab, a digital medical technology company, announced the acquisition of Mint Medical GmbH, a medical technology company proficient in manufacturing image reading and reporting software for clinical routine and research.
The acquisitions will foster growth in the automation of radiology reports through AI anatomical mapping and formulation of holistic data. Apart from that, one of the key reasons behind adopting this strategy is to increase the market share and make use of maximum resources to develop the best quality gamma knife.
A unified Market Research Subscription Platform, built for today's disparate research needs.
High Cost to Challenge Market Growth
The high cost of the gamma knife procedure might be one of the main reasons why the growth rate of the market has been cut down for the forecast period. The cost of a Gamma Knife is in the range of US$ 4 Mn to US$ 5 Mn, with additional setup costs of US$ 1 Mn to US$ 2 Mn. Total investment in procuring a machine can add up to US$ 7 Mn. The high cost of Gamma Knife has remained a longstanding challenge. However, it is expected that technological advancement will lead to cost reduction in the future.
Apart from that, the lack of availability of equipment in a lot of developing and underdeveloped countries might also pose a challenge. This coupled with the lack of knowledge about the existence of such a procedure, is expected to have a negative impact on the gamma knife adoption trends. Moreover, fluctuating reimbursement rates and a scarcity of skilled professionals are factors expected to hamper market growth.
Comparative View for Gamma Knife Market
Gamma Knife Market:
|
Attributes |
Gamma Knife Market |
|
Anticipated CAGR (2023 to 2033) |
5.7% |
|
Market Value (2023) |
US$ 343.1 million |
|
Growth Factor |
Increase in cancer and neurological disorder |
|
Future Opportunities |
Increased collaborations amongst key players |
|
Market Trends |
Surging adoption of gamma knife for treating obesity |
Liposuction Market:
|
Attributes |
Liposuction Market |
|
Anticipated CAGR (2023 to 2033) |
6.8% |
|
Market Value (2023) |
US$ 5.2 billion |
|
Growth Factor |
Reduction in stigma associated with cosmetic reconstruction |
|
Future Opportunities |
Increase in adoption of minimally invasive procedures |
|
Market Trends |
Increasing celebrity endorsements |
Cancer Tissue Diagnostics Market:
|
Attributes |
Cancer Tissue Diagnostics Market |
|
Anticipated CAGR (2023 to 2033) |
6.6% |
|
Market Value (2023) |
US$ 5.8 billion |
|
Growth Factor |
Increase in the cancer cases |
|
Future Opportunities |
High emphasis on individualised cancer treatment |
|
Market Trends |
Technological upgradation in the healthcare sector |
Country-wise Analysis
| Country | United States |
| CAGR (2023-2033) | 6.3% |
| Historical CAGR (2017-2022) | 9% |
| Absolute Dollar Growth | US$ 68.7 Mn |
| Country | United Kingdom |
| CAGR (2023-2033) | 5.9% |
| Historical CAGR (2017-2022) | 9.3% |
| Absolute Dollar Growth | US$ 11.5 Mn |
| Country | Japan |
| CAGR (2023-2033) | 4.6% |
| Historical CAGR (2017-2022) | 8.5% |
| Absolute Dollar Growth | US$ 18 Mn |
| Country | China |
| CAGR (2023-2033) | 5.7% |
| Historical CAGR (2017-2022) | 9.5% |
| Absolute Dollar Growth | US$ 62.8 Mn |
| Country | South Korea |
| CAGR (2023-2033) | 4.3% |
| Historical CAGR (2017-2022) | 8.2% |
| Absolute Dollar Growth | US$ 10.5 Mn |
Surging Cancer Cases to Drive USA Market
The USA market is expected to reach a valuation of US$ 150.9 million by the end of 2033. An increase in the number of cancer cases is supposedly driving the market growth in the country. Based on the data of Cancer Data and Statistics, more than 1.7 million cancer cases were reported in the USA alone.
Furthermore, the gamma knife treatment is a non-invasive form of treatment, which makes it preferable over a lot of other methods. Apart from that, an increasing disposable income is expected to further drive the market growth as it makes the process affordable. Furthermore, as per the statistics collected by FMI, the North America region is the largest market for gamma knife, and the USA market has the largest share of close to 53.5% in the North America region.
UK Market Driven by Huge Parkinson’s disease
The UK market is expected to reach a valuation of US$ 26.4 million by the end of 2033. The market is mainly driven by an increase in the number of patients suffering from Parkinson’s disease. As of 2022, more than 145,000 people are suffering from Parkinson’s in the country.
Apart from that, even the key players who are into gamma knife are making use of the latest technology to improvise the existing versions. They have been funding researchers to bring about innovative practices. With the study detailing the treatment planning of brain metastases for 35 brain lesions from 20 patients, researchers developed treatment plans using cyclotron and LIGHT proton systems as well as the photon systems such as gamma knife radiosurgery.
China Market Riding High on Obese Patients
The China market is expected to reach a valuation of US$ 148.5 million by the end of 2033. A massive surge in the number of obese patients is expected to drive the China market during the forecast period.
Based on a survey conducted, the cosmetic reconstruction market in China is expected to grow at a massive 30% during the forecast period. As a part of this process, a lot of people undergo fat removal procedures through gamma knife surgery. This is expected to surge the market share in China during the forecast period.
Vascular Abnormalities in Japan expected to Surge Market Growth
The Japan market is expected to reach a valuation of US$ 49.4 million by 2033. An increase in the number of cases pertaining to vascular abnormalities is expected to surge the market share. There are a number of people in the region who suffer from problems caused within the veins and the arteries owing to the lifestyle they lead.
Apart from that, the healthcare sector in Japan has been witnessing massive technological upgradation. This has certainly helped with the evolution of the gamma knife market as a result of which the key players are able to keep themselves a notch ahead as compared to players from other regions.
Government Initiatives driving the South Korea Market
The South Korean government has been taking a number of initiatives to ensure the best possible healthcare for its people. Korean public healthcare covers between 50-80% of medical costs depending on the individual’s needs and the treatment they receive. This includes the costs for medical checkups, general procedures, accident coverage, and prescription medication.
This, coupled with the high disposable income of an average South Korean individual, is expected to surge the gamma knife market share during the forecast period. Apart from that, the collaborations between the key players in the healthcare sector and the Korean government are expected to further surge the market share.
Segmentation Analysis
| Segment Name | Disease Indication |
| Top performing sub segment | Brain metastasis |
| Historical CAGR (2017-2022) | 8.8% |
| Segment Name | Anatomy |
| Top performing sub segment | Head |
| Historical CAGR (2017-2022) | 8.6% |
Brain Metastasis Sub-Segment Expected to grow at 5.4%
Brain metastasis holds the highest market share based on the disease indication segment. An increase in the number of cancer cases, especially cerebrum malignancy, and an upgradation of the medical infrastructure are expected to surge the market share of the brain metastasis segment.
A survey conducted by WHO found that cancer was the leading cause of death worldwide in 2020, and around 10 million people died of cancer. The point to be noted over here is that brain cancer forms a major chunk of the market share. Apart from that, when a patient reaches stage 4 cancer, there is a high chance that cancer developed in a body part might spread to the brain as well. All these factors are expected to further surge the market share.
Head to Surge at a CAGR of 5.1%
The higher share of the head segment can be attributed to an increase in the adoption of the non-invasive techniques in general. The adoption rate tends to become higher when treating brain tumour. Apart from that, the side effects involved while undergoing the procedure is almost nil.
Furthermore, the usage of computer guided treatment equipment ensures that the operation is carried out with the highest efficiency. This coupled with the high precision at which the beam strikes the target area ensures that the success rate remains high as compared to a lot of other procedures.
Ability to offer Single or Fractioned Radiation Therapy Driving the Start-up Space
The start-ups operating in the gamma knife market are giving clinicians devices to perform single or fractioned frame-based or frameless radiation therapy. Apart from that, the start-ups are also making use of the radiosurgery method in gamma knife therapy, where the radiation beams are powerfully concentrated at the target. This is done without affecting the healthy tissue.
Apart from that, the start-ups are making use of noncoplanar beams instead of shaped beams, which makes it possible to move some or all shots. This, along with the usage of a 0.15 mm resolution screen, has been developed by the start-ups operating in this space to develop the best quality gamma knife system.
Competitive Landscape
The key players operating in the gamma knife market are implementing predictive service business, which has resulted in important strides in their offerings. The technology implemented by them helps proactively identify linear accelerator component issues that could result in unscheduled downtime. For example, Elekta Care™ Support Services has been making use of the above techniques to make a positive impact on patient care.
Top manufacturers of gamma knife market
| Name | Elketa |
| Company Description |
Elketa is driven by a united PURPOSE that motivates the company and as individuals to keep alive the “Hope for everyone dealing with cancer”. The company is driven by the VISION – “A world where everyone has access to the best cancer care”. The company has been planning to get there through our MISSION – “We improve patient lives by working together with our customers and partners.” As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible. |
| Latest News in gamma knife market | In November 2022, the Swedish and the Jordanian royalty inaugurated the Elekta radiation therapy devices for cancer and brain disease. |
| Name | Varian Medical Systems |
| Company Description |
Varian Medical System has been dedicated to forging a new, more unifying, smarter standard of oncology - connecting us all through more intelligent data, insights, and solutions to realize our vision of a world without fear of cancer. From software and machines to patient data and core teams, Varian’s Intelligent Cancer Care is uniting the world’s cancer fight. Varian hosts several webinar series, covering topics ranging from thought leadership/emerging ideas in oncology to the safe and effective use of Varian technology. |
| Latest News in gamma knife market | In November 2022, Varian Medical Systems announced the first participant treated in GENESIS clinical III trial of Genicular Artery Embolisation for Knee Osteoartritis. |
| Name | Akesis |
| Company Description |
Akesis is focused on ensuring everyone has access to life-saving Radiation Medicine. By combining innovative, advanced technology with proven treatment approaches, Akesis has created the next evolution in Radiation Medicine. Our platform-based development approach allows Akesis to meet the needs of everyone from small rural centers to large academic health systems. Because we are unburdened by legacy designs, we have been free to innovate and improve. |
| Latest News in gamma knife market | In March 2022, Akesis and Macromedics explored advances in head and neck positioning. They recently completed usability testing with a specially designed version of the MacroMedics Double Shell Positioning System (DSPS®) on the Akesis Galaxy® RTi. |
Key Companies in Gamma Knife Market
- Elekta,
- Varian Medical Systems,
- Huiheng Medical, Inc.,
- Akesis, Inc
Gamma Knife Market Segmentation
By Disease Indication:
- Brain Metastasis,
- Cancer,
- Arteriovenous Malformation,
- Trigeminal Neuralgia,
- Others
By Anatomy:
- Head,
- Neck,
- Other Body Parts
By Region:
- North America
- Latin America
- APAC
- MEA
- Europe
Frequently Asked Questions
The global gamma knife market holds a valuation of US$ 343.1 million as of 2023.
The gamma knife market is expected to grow at 5.7% CAGR during 2023-2033.
The global gamma knife market is forecasted to surpass US$ 600 million by 2033.
North America is the largest gamma knife market.
The main drivers are: rising obesity cases and implementation of imaging software.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2022
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Disease Indication
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Disease Indication, 2017-2022
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Disease Indication, 2023-2033
5.3.1. Brain Metastasis
5.3.2. Cancer
5.3.3. Arteriovenous Malformation
5.3.4. Trigeminal Neuralgia
5.3.5. Other Disease Indications
5.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2017-2022
5.5. Absolute $ Opportunity Analysis By Disease Indication, 2023-2033
6. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Anatomy
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Anatomy, 2017-2022
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Anatomy, 2023-2033
6.3.1. Head
6.3.2. Neck
6.3.3. Other Body Parts
6.4. Y-o-Y Growth Trend Analysis By Anatomy, 2017-2022
6.5. Absolute $ Opportunity Analysis By Anatomy, 2023-2033
7. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2022
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. APAC
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017-2022 and Forecast 2023-2033, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Disease Indication
8.2.3. By Anatomy
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Disease Indication
8.3.3. By Anatomy
8.4. Key Takeaways
9. Latin America Market Analysis 2017-2022 and Forecast 2023-2033, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
9.2.1. By Country
9.2.1.1. Argentina
9.2.1.2. Brazil
9.2.1.3. Mexico
9.2.1.4. Rest of Latin America
9.2.2. By Disease Indication
9.2.3. By Anatomy
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Disease Indication
9.3.3. By Anatomy
9.4. Key Takeaways
10. Europe Market Analysis 2017-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. U.K.
10.2.1.2. Germany
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Nordic
10.2.1.7. Benelux
10.2.1.8. Rest of Europe
10.2.2. By Disease Indication
10.2.3. By Anatomy
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Disease Indication
10.3.3. By Anatomy
10.4. Key Takeaways
11. APAC Market Analysis 2017-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. China
11.2.1.2. India
11.2.1.3. ASEAN
11.2.1.4. Australia & New Zealand
11.2.1.5. Rest of APAC
11.2.2. By Disease Indication
11.2.3. By Anatomy
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Disease Indication
11.3.3. By Anatomy
11.4. Key Takeaways
12. MEA Market Analysis 2017-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Rest of MEA
12.2.2. By Disease Indication
12.2.3. By Anatomy
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Disease Indication
12.3.3. By Anatomy
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. U.S.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2022
13.1.2.1. By Disease Indication
13.1.2.2. By Anatomy
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2022
13.2.2.1. By Disease Indication
13.2.2.2. By Anatomy
13.3. Argentina
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2022
13.3.2.1. By Disease Indication
13.3.2.2. By Anatomy
13.4. Brazil
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2022
13.4.2.1. By Disease Indication
13.4.2.2. By Anatomy
13.5. Mexico
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2022
13.5.2.1. By Disease Indication
13.5.2.2. By Anatomy
13.6. U.K.
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2022
13.6.2.1. By Disease Indication
13.6.2.2. By Anatomy
13.7. Germany
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2022
13.7.2.1. By Disease Indication
13.7.2.2. By Anatomy
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2022
13.8.2.1. By Disease Indication
13.8.2.2. By Anatomy
13.9. Spain
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2022
13.9.2.1. By Disease Indication
13.9.2.2. By Anatomy
13.10. Italy
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2022
13.10.2.1. By Disease Indication
13.10.2.2. By Anatomy
13.11. Nordic
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2022
13.11.2.1. By Disease Indication
13.11.2.2. By Anatomy
13.12. Benelux
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2022
13.12.2.1. By Disease Indication
13.12.2.2. By Anatomy
13.13. Russia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2022
13.13.2.1. By Disease Indication
13.13.2.2. By Anatomy
13.14. Poland
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2022
13.14.2.1. By Disease Indication
13.14.2.2. By Anatomy
13.15. China
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2022
13.15.2.1. By Disease Indication
13.15.2.2. By Anatomy
13.16. India
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2022
13.16.2.1. By Disease Indication
13.16.2.2. By Anatomy
13.17. ASEAN
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2022
13.17.2.1. By Disease Indication
13.17.2.2. By Anatomy
13.18. Australia & New Zealand
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2022
13.18.2.1. By Disease Indication
13.18.2.2. By Anatomy
13.19. Japan
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2022
13.19.2.1. By Disease Indication
13.19.2.2. By Anatomy
13.20. GCC Countries
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2022
13.20.2.1. By Disease Indication
13.20.2.2. By Anatomy
13.21. South Africa
13.21.1. Pricing Analysis
13.21.2. Market Share Analysis, 2022
13.21.2.1. By Disease Indication
13.21.2.2. By Anatomy
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Disease Indication
14.3.3. By Anatomy
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Elekta
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Varian Medical Systems
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Huiheng Medical, Inc.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Akesis, Inc.
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2033
Table 2: Global Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033
Table 3: Global Market Value (US$ Mn) Forecast by Anatomy, 2017-2033
Table 4: North America Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 5: North America Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033
Table 6: North America Market Value (US$ Mn) Forecast by Anatomy, 2017-2033
Table 7: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 8: Latin America Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033
Table 9: Latin America Market Value (US$ Mn) Forecast by Anatomy, 2017-2033
Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 11: Europe Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033
Table 12: Europe Market Value (US$ Mn) Forecast by Anatomy, 2017-2033
Table 13: APAC Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 14: APAC Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033
Table 15: APAC Market Value (US$ Mn) Forecast by Anatomy, 2017-2033
Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 17: MEA Market Value (US$ Mn) Forecast by Disease Indication, 2017-2033
Table 18: MEA Market Value (US$ Mn) Forecast by Anatomy, 2017-2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Disease Indication, 2023-2033
Figure 2: Global Market Value (US$ Mn) by Anatomy, 2023-2033
Figure 3: Global Market Value (US$ Mn) by Region, 2023-2033
Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2017-2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 7: Global Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033
Figure 10: Global Market Value (US$ Mn) Analysis by Anatomy, 2017-2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033
Figure 13: Global Market Attractiveness by Disease Indication, 2023-2033
Figure 14: Global Market Attractiveness by Anatomy, 2023-2033
Figure 15: Global Market Attractiveness by Region, 2023-2033
Figure 16: North America Market Value (US$ Mn) by Disease Indication, 2023-2033
Figure 17: North America Market Value (US$ Mn) by Anatomy, 2023-2033
Figure 18: North America Market Value (US$ Mn) by Country, 2023-2033
Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 22: North America Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033
Figure 25: North America Market Value (US$ Mn) Analysis by Anatomy, 2017-2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033
Figure 28: North America Market Attractiveness by Disease Indication, 2023-2033
Figure 29: North America Market Attractiveness by Anatomy, 2023-2033
Figure 30: North America Market Attractiveness by Country, 2023-2033
Figure 31: Latin America Market Value (US$ Mn) by Disease Indication, 2023-2033
Figure 32: Latin America Market Value (US$ Mn) by Anatomy, 2023-2033
Figure 33: Latin America Market Value (US$ Mn) by Country, 2023-2033
Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 37: Latin America Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033
Figure 40: Latin America Market Value (US$ Mn) Analysis by Anatomy, 2017-2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033
Figure 43: Latin America Market Attractiveness by Disease Indication, 2023-2033
Figure 44: Latin America Market Attractiveness by Anatomy, 2023-2033
Figure 45: Latin America Market Attractiveness by Country, 2023-2033
Figure 46: Europe Market Value (US$ Mn) by Disease Indication, 2023-2033
Figure 47: Europe Market Value (US$ Mn) by Anatomy, 2023-2033
Figure 48: Europe Market Value (US$ Mn) by Country, 2023-2033
Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 52: Europe Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033
Figure 53: Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033
Figure 55: Europe Market Value (US$ Mn) Analysis by Anatomy, 2017-2033
Figure 56: Europe Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033
Figure 57: Europe Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033
Figure 58: Europe Market Attractiveness by Disease Indication, 2023-2033
Figure 59: Europe Market Attractiveness by Anatomy, 2023-2033
Figure 60: Europe Market Attractiveness by Country, 2023-2033
Figure 61: APAC Market Value (US$ Mn) by Disease Indication, 2023-2033
Figure 62: APAC Market Value (US$ Mn) by Anatomy, 2023-2033
Figure 63: APAC Market Value (US$ Mn) by Country, 2023-2033
Figure 64: APAC Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 65: APAC Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 66: APAC Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 67: APAC Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033
Figure 68: APAC Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033
Figure 69: APAC Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033
Figure 70: APAC Market Value (US$ Mn) Analysis by Anatomy, 2017-2033
Figure 71: APAC Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033
Figure 72: APAC Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033
Figure 73: APAC Market Attractiveness by Disease Indication, 2023-2033
Figure 74: APAC Market Attractiveness by Anatomy, 2023-2033
Figure 75: APAC Market Attractiveness by Country, 2023-2033
Figure 76: MEA Market Value (US$ Mn) by Disease Indication, 2023-2033
Figure 77: MEA Market Value (US$ Mn) by Anatomy, 2023-2033
Figure 78: MEA Market Value (US$ Mn) by Country, 2023-2033
Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 82: MEA Market Value (US$ Mn) Analysis by Disease Indication, 2017-2033
Figure 83: MEA Market Value Share (%) and BPS Analysis by Disease Indication, 2023-2033
Figure 84: MEA Market Y-o-Y Growth (%) Projections by Disease Indication, 2023-2033
Figure 85: MEA Market Value (US$ Mn) Analysis by Anatomy, 2017-2033
Figure 86: MEA Market Value Share (%) and BPS Analysis by Anatomy, 2023-2033
Figure 87: MEA Market Y-o-Y Growth (%) Projections by Anatomy, 2023-2033
Figure 88: MEA Market Attractiveness by Disease Indication, 2023-2033
Figure 89: MEA Market Attractiveness by Anatomy, 2023-2033
Figure 90: MEA Market Attractiveness by Country, 2023-2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
